查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2046384

心導管和導管導引線市場－全球產業規模、佔有率、趨勢、機會、預測：按產品、最終用戶、地區和競爭對手分類，2021-2031年

Cardiac Catheters And Guidewires Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Cardiac Catheters, Cardiac Guidewires), By End user, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球心臟導管和導管導引線市場預計將從 2025 年的 160.1 億美元大幅成長至 2031 年的 248.9 億美元，複合年成長率為 7.63%。

這些專用醫療設備在介入性心臟病學中至關重要。導管作為軟性管道，用於進入心臟進行治療和診斷；導管導引線用於精準引導患者通過血管。推動這一市場發展的主要因素是全球心血管疾病負擔日益加重，這導致血管成形術和血管造影術的數量不斷增加。人口老化以及臨床上對微創手術而非傳統開胸手術的偏好進一步推動了這一需求。美國心臟協會發布的《2025年心血管和中風統計更新》報告也印證了這個現實：2021年全球約有1,941萬人死於心血管疾病。

市場概覽
預測期 2027-2031
市場規模：2025年 160.1億美元
市場規模：2031年 248.9億美元
複合年成長率：2026-2031年 7.63%
成長最快的細分市場 心臟導管
最大的市場 北美洲

儘管市場成長勢頭強勁，但由於嚴格的法規結構和高昂的產品核可成本，該市場仍面臨許多障礙。製造商必須遵守複雜的合規標準，例如歐盟的醫療設備法規 (MDR)，這會延長研發週期並需要大量資金投入。這些監管障礙常常延緩新技術上市，並可能在對成本高度敏感的醫療保健市場中限制患者獲得先進醫療設備的機會。

市場促進因素

全球心血管疾病發生率的不斷上升是全球心臟導管和導管導引線市場的主要驅動力，對診斷和治療程序的需求持續成長。隨著心臟衰竭和冠狀動脈疾病等疾病的日益普遍，醫療系統正優先考慮基於導管的治療，以有效改善患者預後並降低死亡率。近期死亡率統計數據凸顯了這日益加重的疾病負擔。根據美國疾病管制與預防中心 (CDC) 2024 年 5 月發布的《心臟病概況》報告，光是冠狀動脈疾病一項，2022 年就導致美國 371,506 人死亡。因此，主要醫療設備製造商的循環系統業務收入顯著成長，波士頓科學公司發布的《2024 年第三季財務業績》累計了這一點，該公司循環系統部門的淨銷售額約為 21.3 億美元。

導管和導管導引線工程領域的技術創新正在革新市場，提高手術精度並擴大微創治療的範圍。製造商正迅速推出操控性更佳、標測功能更先進的新一代設備，使電生理學家能夠更安全、更有效地操控複雜的血管通路。這些技術突破，尤其是在診斷和消融導管領域，正推動尋求最佳化手術流程的醫療專業人員迅速採用這些技術。根據雅培公司於2024年10月發布的2024年第三季財報，電生理業務的銷售額實現了14.3%的有機成長，這主要得益於導管和心臟定位產品的兩位數成長。這凸顯了這些技術在現代心臟病學中所扮演的關鍵角色。

市場挑戰

嚴格的法規結構和高昂的產品核可成本是限制全球心臟導管和導管導引線市場成長的主要障礙。製造商日益受到複雜合規標準的束縛，這些標準要求在醫療設備上市前提供大量的臨床數據和嚴格的文件記錄。沉重的監管負擔延長了研發週期，迫使企業將大量資金從創新轉移到滿足行政要求。因此，先進心臟技術的商業化過程經常被延誤，限制了新設備的供應，並造成了嚴重的瓶頸，減緩了整體市場的發展勢頭。

近期產業數據顯示，這些監管障礙的影響不容忽視，認證週期尤其突出。根據2024年版《歐洲醫療技術展》（MedTech Europe）的數據，醫療設備獲得指定認證機構認證的平均時間為13至18個月，是先前指令規定所需時間的兩倍。如此漫長的認證過程不僅阻礙​​了產生收入，也直接限制了市場擴張，使得製造商在監管最嚴格的地區推出尖端產品時猶豫不決。

市場趨勢

機器人輔助導管插入和導航系統的整合正在改變市場上手術的精確度和安全性。這些先進的平台使介入醫生能夠在輻射屏蔽的駕駛座內以亞毫米級的精度操控導管和導管導引線，從而顯著降低複雜手術過程中的職業輻射暴露和身體疲勞。製造商正積極推出更緊湊、更易於使用的機器人單元，這些單元與新型磁性導航導管無縫整合，可自動在複雜的解剖結構內移動。這項技術變革得益於專用機器人耗材日益成長的商業性應用。根據 Stereotaxis 公司於 2025 年 11 月發布的 2025 年第三季財報，其經常性收入達到 560 萬美元，這主要得益於新型專有機器人導航設備（例如 MAGIC 消融導管）的應用。

同時，對有利的報銷模式和經濟高效的醫療服務的需求正促使心臟介入手術從傳統醫院轉向門診手術中心（ASC）。監管機構正在擴大已通過核准的門診服務範圍，包括診斷性導管插入術和經皮冠狀動脈介入治療（PCI），並鼓勵醫療機構在其診所內建立專業檢查室。這種結構性轉變簡化了工作流程，縮短了病患出院時間，同時維持了與住院機構相同的臨床安全標準。預計這種轉變的規模將顯著擴大。根據美國心血管血管造影術和介入學會（SCAI）2025年5月發布的一項研究報告《全國調查：門診手術中心在社會弱勢地區為心臟介入患者提供的治療量增加了15%》，預計2024年至2034年間，門診手術中心的手術量將成長21%。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球心臟導管與導管導引線市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 產品類別（心臟導管（電生理導管、 PTCA球囊導管、 IVUS導管、PTA球囊導管、導引管延長導管）、心臟導管導引線）
    • 依最終使用者（醫院/診所、門診中心、其他）分類
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美心導管與導管導引線市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲心導管與導管導引線市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區心導管和導管導引線市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲心臟導管和導管導引線市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美心導管與導管導引線市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球心臟導管與導管導引線市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Abbott Laboratories inc.
  • Boston Scientific Corp.
  • Getinge AB
  • Biosense Webster, Inc
  • Terumo Medical Corp.
  • BIOTRONIK SE & Co. KG
  • Medtronic plc
  • Teleflex Inc.
  • Merit Medical Systems
  • BrosMed Medical Co., Ltd.

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 19364

The Global Cardiac Catheters And Guidewires Market is projected to expand significantly, growing from USD 16.01 Billion in 2025 to USD 24.89 Billion by 2031 at a CAGR of 7.63%. These specialized medical devices are fundamental to interventional cardiology, with catheters serving as flexible tubes for therapeutic or diagnostic heart access and guidewires providing precise navigation through the vasculature. The primary force driving this market is the increasing global burden of cardiovascular conditions, which necessitates a higher volume of angioplasty and angiography procedures. This demand is further bolstered by an aging population and a distinct clinical preference for minimally invasive surgeries over traditional open-heart methods. Highlighting this prevalence, the American Heart Association's "2025 Heart Disease and Stroke Statistics Update" noted that cardiovascular disease was responsible for approximately 19.41 million deaths globally in 2021.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 16.01 Billion
Market Size 2031USD 24.89 Billion
CAGR 2026-20317.63%
Fastest Growing SegmentCardiac Catheters
Largest MarketNorth America

Despite this strong growth trajectory, the market faces substantial obstacles due to stringent regulatory frameworks and the high costs associated with product approval. Manufacturers must navigate complex compliance standards, such as the European Union's Medical Device Regulation, which can extend development cycles and require significant financial investment. These regulatory hurdles frequently delay the commercialization of new technologies and may restrict patient access to advanced devices in healthcare markets that are sensitive to costs.

Market Driver

The rising global incidence of cardiovascular diseases acts as the primary catalyst for the Global Cardiac Catheters And Guidewires Market, necessitating a consistently higher volume of diagnostic and interventional procedures. As conditions such as heart failure and coronary artery disease become more prevalent, healthcare systems are prioritizing catheter-based interventions to effectively manage patient outcomes and reduce mortality rates. This escalating disease burden is emphasized by recent mortality statistics; according to the Centers for Disease Control and Prevention's May 2024 "Heart Disease Facts," coronary heart disease alone caused 371,506 deaths in the United States in 2022. Consequently, leading medical device manufacturers are seeing substantial revenue growth in their cardiology divisions, as evidenced by Boston Scientific Corporation's "Results for Third Quarter 2024," where the Cardiology segment generated approximately $2.13 billion in net sales.

Technological innovations in catheter and guidewire engineering are simultaneously revolutionizing the market by improving procedural precision and broadening the scope of minimally invasive treatments. Manufacturers are rapidly introducing next-generation devices with improved steerability and advanced mapping capabilities, allowing electrophysiologists to navigate complex vascular pathways with greater safety and efficacy. These engineering breakthroughs, particularly in diagnostic and ablation catheters, are driving rapid adoption among healthcare providers seeking to optimize surgical workflows. According to Abbott's "Third Quarter 2024 Financial Results" from October 2024, Electrophysiology sales grew 14.3 percent on an organic basis, driven significantly by double-digit growth in catheters and cardiac mapping products, reinforcing the pivotal role of these technologies in modern cardiology.

Market Challenge

The stringent regulatory frameworks and exorbitant costs associated with product approval constitute the primary challenge impeding the growth of the Global Cardiac Catheters And Guidewires Market. Manufacturers are increasingly burdened by complex compliance standards that require extensive clinical data and rigorous documentation before devices can enter the market. This heavy regulatory weight prolongs development cycles and forces companies to divert substantial capital away from innovation toward meeting administrative requirements. Consequently, the commercialization of advanced cardiac technologies is frequently delayed, creating significant bottlenecks that restrict the availability of new devices and dampen overall market momentum.

The impact of these regulatory hurdles is substantiated by recent industry data regarding certification timelines. According to "MedTech Europe" in "2024," the average time-to-certification for medical devices by designated Notified Bodies extended to between 13 and 18 months, representing a twofold increase compared to the duration required under previous directives. Such extended delays directly hamper market expansion by stalling revenue generation and discouraging manufacturers from launching cutting-edge products in regions with the most severe regulatory constraints.

Market Trends

The integration of robotic-assisted catheterization and navigation systems is transforming procedural accuracy and safety within the market. These advanced platforms allow interventionalists to manipulate catheters and guidewires with sub-millimeter precision from radiation-shielded cockpits, significantly mitigating occupational radiation exposure and reducing physical fatigue during complex interventions. Manufacturers are actively launching compact, more accessible robotic units that integrate seamlessly with novel magnetic navigation catheters to automate movement through tortuous anatomy. This technological shift is evidenced by the growing commercial traction of specialized robotic consumables; according to Stereotaxis' "2025 Third Quarter Financial Results" in November 2025, recurring revenue reached $5.6 million, driven significantly by the adoption of new proprietary robotically navigated devices like the MAGiC ablation catheter.

Simultaneously, interventional cardiac procedures are increasingly migrating from traditional hospitals to Ambulatory Surgical Centers (ASCs), driven by favorable reimbursement models and the need for cost-efficient care delivery. Regulatory bodies are expanding the list of approved outpatient services, including diagnostic catheterizations and percutaneous coronary interventions, which encourages healthcare providers to operationalize specialized office-based labs. This structural shift streamlines workflows and accelerates patient discharge times while maintaining clinical safety standards comparable to inpatient facilities. The scale of this transition is projected to expand substantially; according to the Society for Cardiovascular Angiography & Interventions' May 2025 study, "Nationwide Study Finds Ambulatory Surgery Centers Treat 15% More Patients in Socially Vulnerable Areas for Cardiac Interventions," the volume of procedures performed in ASCs is anticipated to increase by 21% between 2024 and 2034.

Key Market Players

  • Abbott Laboratories inc.
  • Boston Scientific Corp.
  • Getinge AB
  • Biosense Webster, Inc
  • Terumo Medical Corp.
  • BIOTRONIK SE & Co. KG
  • Medtronic plc
  • Teleflex Inc.
  • Merit Medical Systems
  • BrosMed Medical Co., Ltd.

Report Scope

In this report, the Global Cardiac Catheters And Guidewires Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cardiac Catheters And Guidewires Market, By Product

  • Cardiac Catheters
  • Cardiac Guidewires

Cardiac Catheters And Guidewires Market, By End user

  • Hospitals & Clinics
  • Ambulatory Care Centers
  • Others

Cardiac Catheters And Guidewires Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Cardiac Catheters And Guidewires Market.

Available Customizations:

Global Cardiac Catheters And Guidewires Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Cardiac Catheters And Guidewires Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Cardiac Catheters (Electrophysiology catheters, PTCA balloon catheters, IVUS catheters, PTA balloon catheters, Guide extension catheter), Cardiac Guidewires)
    • 5.2.2. By End user (Hospitals & Clinics, Ambulatory Care Centers, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Cardiac Catheters And Guidewires Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By End user
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Cardiac Catheters And Guidewires Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By End user
    • 6.3.2. Canada Cardiac Catheters And Guidewires Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By End user
    • 6.3.3. Mexico Cardiac Catheters And Guidewires Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By End user

7. Europe Cardiac Catheters And Guidewires Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By End user
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Cardiac Catheters And Guidewires Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By End user
    • 7.3.2. France Cardiac Catheters And Guidewires Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By End user
    • 7.3.3. United Kingdom Cardiac Catheters And Guidewires Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By End user
    • 7.3.4. Italy Cardiac Catheters And Guidewires Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By End user
    • 7.3.5. Spain Cardiac Catheters And Guidewires Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By End user

8. Asia Pacific Cardiac Catheters And Guidewires Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By End user
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Cardiac Catheters And Guidewires Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By End user
    • 8.3.2. India Cardiac Catheters And Guidewires Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By End user
    • 8.3.3. Japan Cardiac Catheters And Guidewires Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By End user
    • 8.3.4. South Korea Cardiac Catheters And Guidewires Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By End user
    • 8.3.5. Australia Cardiac Catheters And Guidewires Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By End user

9. Middle East & Africa Cardiac Catheters And Guidewires Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By End user
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Cardiac Catheters And Guidewires Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By End user
    • 9.3.2. UAE Cardiac Catheters And Guidewires Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By End user
    • 9.3.3. South Africa Cardiac Catheters And Guidewires Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By End user

10. South America Cardiac Catheters And Guidewires Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By End user
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Cardiac Catheters And Guidewires Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By End user
    • 10.3.2. Colombia Cardiac Catheters And Guidewires Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By End user
    • 10.3.3. Argentina Cardiac Catheters And Guidewires Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By End user

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Cardiac Catheters And Guidewires Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Abbott Laboratories inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Boston Scientific Corp.
  • 15.3. Getinge AB
  • 15.4. Biosense Webster, Inc
  • 15.5. Terumo Medical Corp.
  • 15.6. BIOTRONIK SE & Co. KG
  • 15.7. Medtronic plc
  • 15.8. Teleflex Inc.
  • 15.9. Merit Medical Systems
  • 15.10. BrosMed Medical Co., Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer